William Blair & Company
NMTR

William Blair & Company’s 9 Meters Biopharma NMTR Stock Holding History

William Blair & Company’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,420
Closed -$7K – 1905
2022
Q2 		$7K Hold
1,420
– – ﹤0.01% 1790
2022
Q1 		$17K Sell
1,420
-2,676
-65% -$36.5K ﹤0.01% 1806
2021
Q4 		$80K Buy
4,096
+2,696
+193% +$60.3K ﹤0.01% 1722
2021
Q3 		$36K Hold
1,400
– – ﹤0.01% 1714
2021
Q2 		$31K Hold
1,400
– – ﹤0.01% 1745
2021
Q1 		$33K Buy
1,400
+200
+17% +$6.15K ﹤0.01% 1707
2020
Q4 		$21K Hold
1,200
– – ﹤0.01% 1699
2020
Q3 		$20K Buy
+1,200
New +$14.6K ﹤0.01% 1581

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

William Blair & Company's NMTR Position: Q3 2022 in Review

William Blair & Company sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 1,420 shares — an estimated $7K sold.

William Blair & Company first reported a position in NMTR in Q3 2020 and held it in 8 quarters. The position peaked at $80K in Q4 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • William Blair & Company reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • William Blair & Company sold 1,420 9 Meters Biopharma shares in Q3 2022, an estimated $7K.
  • William Blair & Company first reported a position in 9 Meters Biopharma in Q3 2020 and held it in 8 quarters.
  • William Blair & Company's 9 Meters Biopharma position peaked at $80K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on William Blair & Company's 13F filing for Q3 2022, filed 9 Nov 2022.